BeStock  
Stocks › Biotechnology › NKTR

Nektar Therapeutics NKTR

US equityMarket cap rank #3135Biotechnology
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership110.4%+5.05 pts vs. prior quarter
Institutions holding279+6 vs. prior quarter
Insider trades (recent)27 buys / 23 sellsNet buying
Short interest19.82% of floatDays to cover 10.3 · as of 30 Oct 2026
Short-sale volume share22.6%5-day average of daily volume

Short-sale volume as % of daily volume

7%17%27%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.74M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$2.5MSuper+$783.6KBig−$585.6KMid−$1.7MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 45.4% of shares outstanding.

Largest holders

  • FMR15.00%
  • Two Seas Capital LP9.80%
  • BlackRock8.41%
  • BVF Partners L.P.7.00%
  • State Street Global Advisors5.19%
  • Vanguard Capital Management, LLC4.40%
  • Two Sigma Investments, LP3.52%
  • Vestal Point Capital, LP2.93%

By investor type

  • Mutual Fund53.94%
  • Hedge Fund43.03%
  • Public Company5.32%
  • VC/PE Fund4.15%
  • Private Company2.60%
  • Sovereign Wealth Fund0.63%
  • Government Pension Fund0.41%
  • Individual/Insider0.37%

Reported short interest has risen from 18.07% to 19.82% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
State Street Global Advisors Mutual Fund 2026/Q3 +862,623 5.2%
Two Seas Capital LP Hedge Fund 2026/Q3 +253,744 9.8%
Citigroup Inc. Public Company 2026/Q3 +178,065 0.8%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +96,720 0.3%
ACT Capital Management Hedge Fund 2026/Q3 +90,400 0.5%
Jane Street Group, LLC Private Company 2026/Q3 +83,927 0.3%
Two Seas Capital LP Hedge Fund 2026/Q3 +253,744 9.8%
BlackRock Mutual Fund 2026/Q3 +2,249,201 8.6%
FMR Mutual Fund 2026/Q3 +764,713 14.8%
Vestal Point Capital, LP Hedge Fund 2026/Q3 +715,000 2.9%
State Street Global Advisors Mutual Fund 2026/Q3 +664,952 2.7%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +534,511 2.6%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +370,061 5.1%
Gilder Gagnon Howe & Co. LLC Mutual Fund 2026/Q3 +329,115 1.8%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +300,000 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
22 Sep 2026 Robert Chess Independent Chairperson Other Acquisition +2,000 – 2,000
22 Sep 2026 Robert Chess Independent Chairperson Other Derivative Acquisition +4,000 $57.66 4,000
22 Sep 2026 R. Greer Independent Director Other Acquisition +2,000 – 2,000
22 Sep 2026 R. Greer Independent Director Other Derivative Acquisition +4,000 $57.66 4,000
22 Sep 2026 Roy Whitfield Lead Independent Director Other Acquisition +2,000 – 2,000
22 Sep 2026 Roy Whitfield Lead Independent Director Other Derivative Acquisition +4,000 $57.66 4,000
22 Sep 2026 Jeffrey Ajer Independent Director Other Acquisition +2,000 – 2,000
22 Sep 2026 Jeffrey Ajer Independent Director Other Derivative Acquisition +4,000 $57.66 4,000
22 Sep 2026 Diana Brainard Independent Director Other Acquisition +2,000 – 2,000
22 Sep 2026 Diana Brainard Independent Director Other Derivative Acquisition +4,000 $57.66 4,000
17 Aug 2026 Howard Robin Chief Executive Officer Open Market Disposition -418 $71.98 54,655
17 Aug 2026 Jonathan Zalevsky Senior VP and Chief Research & Development Officer Open Market Disposition -186 $71.98 9,570
23 Jul 2026 Howard Robin Chief Executive Officer Other Derivative Acquisition +57,200 $15.15 57,200
23 Jul 2026 Jonathan Zalevsky Senior VP and Chief Research & Development Officer Other Derivative Acquisition +16,500 $15.15 16,500
29 Jun 2026 Jonathan Zalevsky Senior VP and Chief Research & Development Officer Automatic Disposition -5,681 $70.00 9,756
16 Jun 2026 Howard Robin Chief Executive Officer Intent to Sell (Form 144) -10,000 $60.27 –
16 Jun 2026 Howard Robin Chief Executive Officer Automatic Disposition -20,000 $61.65 55,073
15 Jun 2026 Howard Robin Chief Executive Officer Intent to Sell (Form 144) -10,000 $60.96 –
14 Jun 2026 Jonathan Zalevsky Senior VP and Chief Research & Development Officer Automatic Disposition -5,538 $60.71 15,437
18 May 2026 Howard Robin Chief Executive Officer Open Market Disposition -444 $65.51 75,073

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,766,027 19.8% 10.3
15 Oct 2026 6,997,725 20.5% 3.5
30 Sep 2026 6,968,325 20.4% 3.8
15 Sep 2026 5,735,633 16.8% 7.6
31 Aug 2026 6,068,214 17.8% 11.5
14 Aug 2026 6,168,872 18.1% 10.4

Discussion

No comments yet — be the first to weigh in on NKTR.

Sign in to join the discussion.

Scroll to Top